Andreas Ouranidis

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Reduced Graphene Oxide

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Davidopoulou, Andreas Ouranidis
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions. Pharmaceutics 14 (10) (2022)
Andreas Ouranidis, Christina Davidopoulou, Kyriakos Kachrimanis
Integrating Elastic Tensor and PC-SAFT Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline Suspensions. Pharmaceutics 13 (11) (2021)
Anastasia Tsiaxerli, Anna Karagianni, Andreas Ouranidis, Kyriakos Kachrimanis
Polyelectrolyte Matrices in the Modulation of Intermolecular Electrostatic Interactions for Amorphous Solid Dispersions: A Comprehensive Review. Pharmaceutics 13 (9) (2021)
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K Markopoulou, Anna Karagianni, Kyriakos Kachrimanis
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 10 (1) (2021)
Andreas Ouranidis, Christina Davidopoulou, Reald-Konstantinos Tashi, Kyriakos Kachrimanis
Pharma 4.0 Continuous mRNA Drug Products Manufacturing. Pharmaceutics 13 (9) (2021)
Andreas Ouranidis, Theodora Choli-Papadopoulou, Eleni T Papachristou, Rigini Papi, Nikolaos Kostomitsopoulos
Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models. Vaccines 9 (8) (2021)